Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 152

1.

Meropenem-tobramycin combination regimens combat carbapenem-resistant Pseudomonas aeruginosa in the hollow-fiber infection model simulating augmented renal clearance in critically ill patients.

Yadav R, Bergen PJ, Rogers KE, Kirkpatrick CMJ, Wallis SC, Huang Y, Bulitta JB, Paterson DL, Lipman J, Nation RL, Roberts JA, Landersdorfer CB.

Antimicrob Agents Chemother. 2019 Oct 21. pii: AAC.01679-19. doi: 10.1128/AAC.01679-19. [Epub ahead of print]

PMID:
31636062
2.

The frequency and nature of clinician identified medication-related rapid response system calls.

Levkovich BJ, Bingham G, Orosz J, Cooper DJJ, Kirkpatrick CM, Dooley MJ, Jones DA.

Resuscitation. 2019 Oct 11;145:75-78. doi: 10.1016/j.resuscitation.2019.09.033. [Epub ahead of print]

PMID:
31610227
3.

Pharmacometrics in Australasia-Twenty Years of Population Approach Group of Australia and New Zealand.

Hennig S, Hannam JA, Kirkpatrick CMJ, Staatz CE, Holford S, Duffull SB, Al-Sallami HS, Charles BG, Holford N, Foster DJR.

CPT Pharmacometrics Syst Pharmacol. 2019 Oct;8(10):701-704. doi: 10.1002/psp4.12460. Epub 2019 Sep 16. No abstract available.

4.

Unifying a profession and a health care system: Building the case for a "one pharmacy" global community.

Easter JC, Jani YH, Kirkpatrick CM, Steeb DR, Eckel SF.

Res Social Adm Pharm. 2019 Apr 25. pii: S1551-7411(19)30378-X. doi: 10.1016/j.sapharm.2019.04.048. [Epub ahead of print]

PMID:
31097379
5.

An Observational Analysis of Medication Use During 5,727 Medical Emergency Team Activations at a Tertiary Referral Hospital.

Levkovich BJ, Bingham G, Hopkins RE, Jones D, Cooper DJJ, Kirkpatrick CM, Dooley MJ.

Jt Comm J Qual Patient Saf. 2019 Jul;45(7):502-508. doi: 10.1016/j.jcjq.2019.03.001. Epub 2019 Apr 23.

PMID:
31027948
6.

Evaluation of a pharmacist-led penicillin allergy de-labelling ward round: a novel antimicrobial stewardship intervention.

Devchand M, Kirkpatrick CMJ, Stevenson W, Garrett K, Perera D, Khumra S, Urbancic K, Grayson ML, Trubiano JA.

J Antimicrob Chemother. 2019 Jun 1;74(6):1725-1730. doi: 10.1093/jac/dkz082.

PMID:
30869124
7.

The dosing and monitoring of vancomycin: what is the best way forward?

Drennan PG, Begg EJ, Gardiner SJ, Kirkpatrick CMJ, Chambers ST.

Int J Antimicrob Agents. 2019 Apr;53(4):401-407. doi: 10.1016/j.ijantimicag.2018.12.014. Epub 2018 Dec 29. Review.

PMID:
30599240
8.

Respiratory syncytial virus-A dynamics and the effects of lumicitabine, a nucleoside viral replication inhibitor, in experimentally infected humans.

Patel K, Kirkpatrick CM, Nieforth KA, Chanda S, Zhang Q, McClure M, Fry J, Symons JA, Blatt LM, Beigelman L, DeVincenzo JP, Huntjens DR, Smith PF.

J Antimicrob Chemother. 2019 Feb 1;74(2):442-452. doi: 10.1093/jac/dky415.

PMID:
30376079
9.

Optimizing vancomycin dosage regimens in relation to high-flux haemodialysis.

Hui K, Patel K, Nalder M, Nelson C, Buising K, Pedagogos E, Kong DCM, Kirkpatrick CMJ.

J Antimicrob Chemother. 2019 Jan 1;74(1):130-134. doi: 10.1093/jac/dky371.

PMID:
30215721
10.

An analysis of allele, genotype and phenotype frequencies, actionable pharmacogenomic (PGx) variants and phenoconversion in 5408 Australian patients genotyped for CYP2D6, CYP2C19, CYP2C9 and VKORC1 genes.

Mostafa S, Kirkpatrick CMJ, Byron K, Sheffield L.

J Neural Transm (Vienna). 2019 Jan;126(1):5-18. doi: 10.1007/s00702-018-1922-0. Epub 2018 Sep 6.

PMID:
30191366
11.

A Regression Approach to Visual Predictive Checks for Population Pharmacometric Models.

Jamsen KM, Patel K, Nieforth K, Kirkpatrick CMJ.

CPT Pharmacometrics Syst Pharmacol. 2018 Oct;7(10):678-686. doi: 10.1002/psp4.12319. Epub 2018 Sep 10.

12.

Understanding how medications contribute to clinical deterioration and are used in rapid response systems: A comprehensive scoping review.

Levkovich BJ, Bingham G, Jones D, Kirkpatrick CM, Cooper DJJ, Dooley MJ.

Aust Crit Care. 2019 May;32(3):256-272. doi: 10.1016/j.aucc.2018.05.006. Epub 2018 Jul 11. Review.

PMID:
30005938
13.

Qualitative evaluation of how a virtual dementia experience impacts medical and pharmacy students' self-reported knowledge and attitudes towards people with dementia.

Gilmartin-Thomas JF, McNeil J, Powell A, Malone DT, Larson IC, O'Reilly CL, Kirkpatrick CM, Kipen E, Petrovich T, Ryan-Atwood TE, Bell JS.

Dementia (London). 2018 Jan 1:1471301218770270. doi: 10.1177/1471301218770270. [Epub ahead of print]

PMID:
29661097
14.

Effect of Perioperative Opioids on Cancer-Relevant Circulating Parameters: Mu Opioid Receptor and Toll-Like Receptor 4 Activation Potential, and Proteolytic Profile.

Xie N, Matigian N, Vithanage T, Gregory K, Nassar ZD, Cabot PJ, Shaw PN, Kirkpatrick CMJ, Cao KL, Sturgess D, Parat MO.

Clin Cancer Res. 2018 May 15;24(10):2319-2327. doi: 10.1158/1078-0432.CCR-18-0172. Epub 2018 Mar 6.

15.

Impact of a Virtual Dementia Experience on Medical and Pharmacy Students' Knowledge and Attitudes Toward People with Dementia: A Controlled Study.

Gilmartin-Thomas JF, McNeil J, Powell A, Malone DT, Wolfe R, Larson IC, O'Reilly CL, Kirkpatrick CM, Kipen E, Petrovich T, Bell JS.

J Alzheimers Dis. 2018;62(2):867-876. doi: 10.3233/JAD-170982.

PMID:
29480198
16.

Optimization and Evaluation of Piperacillin-Tobramycin Combination Dosage Regimens against Pseudomonas aeruginosa for Patients with Altered Pharmacokinetics via the Hollow-Fiber Infection Model and Mechanism-Based Modeling.

Yadav R, Rogers KE, Bergen PJ, Bulitta JB, Kirkpatrick CMJ, Wallis SC, Paterson DL, Nation RL, Lipman J, Roberts JA, Landersdorfer CB.

Antimicrob Agents Chemother. 2018 Apr 26;62(5). pii: e00078-18. doi: 10.1128/AAC.00078-18. Print 2018 May.

17.

Cost-utility analysis of antiviral use under pandemic influenza using a novel approach - linking pharmacology, epidemiology and heath economics.

Wu DBC, Chaiyakunapruk N, Pratoomsoot C, Lee KKC, Chong HY, Nelson RE, Smith PF, Kirkpatrick CM, Kamal MA, Nieforth K, Dall G, Toovey S, Kong DCM, Kamauu A, Rayner CR.

Epidemiol Infect. 2018 Mar;146(4):496-507. doi: 10.1017/S0950268818000158. Epub 2018 Feb 15.

PMID:
29446343
18.

Differences in suppression of regrowth and resistance despite similar initial bacterial killing for meropenem and piperacillin/tazobactam against Pseudomonas aeruginosa and Escherichia coli.

Bergen PJ, Bulitta JB, Sime FB, Lipman J, McGregor MJ, Millen N, Paterson DL, Kirkpatrick CMJ, Roberts JA, Landersdorfer CB.

Diagn Microbiol Infect Dis. 2018 May;91(1):69-76. doi: 10.1016/j.diagmicrobio.2017.12.019. Epub 2018 Jan 3.

PMID:
29395712
19.

Vancomycin dosing in chronic high-flux haemodialysis: a systematic review.

Hui K, Upjohn L, Nalder M, Buising K, Pedagogos E, Nelson C, Kirkpatrick CMJ, Kong DCM.

Int J Antimicrob Agents. 2018 May;51(5):678-686. doi: 10.1016/j.ijantimicag.2017.12.017. Epub 2017 Dec 25.

PMID:
29284156
20.

Prevalence and Variability in Medications Contributing to Polypharmacy in Long-Term Care Facilities.

Jokanovic N, Jamsen KM, Tan ECK, Dooley MJ, Kirkpatrick CM, Bell JS.

Drugs Real World Outcomes. 2017 Dec;4(4):235-245. doi: 10.1007/s40801-017-0121-x.

21.

Cardiovascular disease risk profile of NCAA Division III intercollegiate football athletes: a pilot study.

Wright CJ, Abbey EL, Brandon BA, Reisman EJ, Kirkpatrick CM.

Phys Sportsmed. 2017 Sep;45(3):280-285. doi: 10.1080/00913847.2017.1345288. Epub 2017 Jun 28.

PMID:
28632483
22.

Medication Use and Fall-Related Hospital Admissions from Long-Term Care Facilities: A Hospital-Based Case-Control Study.

Ryan-Atwood TE, Hutchinson-Kern M, Ilomäki J, Dooley MJ, Poole SG, Kirkpatrick CM, Manias E, Mitra B, Bell JS.

Drugs Aging. 2017 Aug;34(8):625-633. doi: 10.1007/s40266-017-0472-8.

PMID:
28573553
23.

Nutrition practices and knowledge among NCAA Division III football players.

Abbey EL, Wright CJ, Kirkpatrick CM.

J Int Soc Sports Nutr. 2017 May 19;14:13. doi: 10.1186/s12970-017-0170-2. eCollection 2017.

24.

Impact of high-flux haemodialysis on the probability of target attainment for oral amoxicillin/clavulanic acid combination therapy.

Hui K, Patel K, Kong DCM, Kirkpatrick CMJ.

Int J Antimicrob Agents. 2017 Jul;50(1):110-113. doi: 10.1016/j.ijantimicag.2017.02.021. Epub 2017 May 11.

PMID:
28502697
25.

Patterns of use and appropriateness of antibiotics prescribed to patients receiving haemodialysis: an observational study.

Hui K, Nalder M, Buising K, Pefanis A, Ooi KY, Pedagogos E, Nelson C, Kirkpatrick CMJ, Kong DCM.

BMC Nephrol. 2017 May 12;18(1):156. doi: 10.1186/s12882-017-0575-9.

26.

A dosing algorithm for metformin based on the relationships between exposure and renal clearance of metformin in patients with varying degrees of kidney function.

Duong JK, Kroonen MYAM, Kumar SS, Heerspink HL, Kirkpatrick CM, Graham GG, Williams KM, Day RO.

Eur J Clin Pharmacol. 2017 Aug;73(8):981-990. doi: 10.1007/s00228-017-2251-1. Epub 2017 Apr 28.

PMID:
28451709
27.

Lumbar Facet Tropism: A Comprehensive Review.

Alonso F, Kirkpatrick CM, Jeong W, Fisahn C, Usman S, Rustagi T, Loukas M, Chapman JR, Oskouian RJ, Tubbs RS.

World Neurosurg. 2017 Jun;102:91-96. doi: 10.1016/j.wneu.2017.02.114. Epub 2017 Mar 6. Review.

PMID:
28279769
28.

Substantial Impact of Altered Pharmacokinetics in Critically Ill Patients on the Antibacterial Effects of Meropenem Evaluated via the Dynamic Hollow-Fiber Infection Model.

Bergen PJ, Bulitta JB, Kirkpatrick CMJ, Rogers KE, McGregor MJ, Wallis SC, Paterson DL, Nation RL, Lipman J, Roberts JA, Landersdorfer CB.

Antimicrob Agents Chemother. 2017 Apr 24;61(5). pii: e02642-16. doi: 10.1128/AAC.02642-16. Print 2017 May.

29.

Interdisciplinary pharmacometrics linking oseltamivir pharmacology, influenza epidemiology and health economics to inform antiviral use in pandemics.

Kamal MA, Smith PF, Chaiyakunapruk N, Wu DBC, Pratoomsoot C, Lee KKC, Chong HY, Nelson RE, Nieforth K, Dall G, Toovey S, Kong DCM, Kamauu A, Kirkpatrick CM, Rayner CR.

Br J Clin Pharmacol. 2017 Jul;83(7):1580-1594. doi: 10.1111/bcp.13229. Epub 2017 Feb 20.

30.

Developing a Framework for Objective Structured Clinical Examinations Using the Nominal Group Technique.

Hussainy SY, Crum MF, White PJ, Larson I, Malone DT, Manallack DT, Nicolazzo JA, McDowell J, Lim AS, Kirkpatrick CM.

Am J Pharm Educ. 2016 Nov 25;80(9):158. doi: 10.5688/ajpe809158.

31.

Adverse Drug Reactions Associated With Cholinesterase Inhibitors-Sequence Symmetry Analyses Using Prescription Claims Data.

Venäläinen O, Bell JS, Kirkpatrick CM, Nishtala PS, Liew D, Ilomäki J.

J Am Med Dir Assoc. 2017 Feb 1;18(2):186-189. doi: 10.1016/j.jamda.2016.11.002. Epub 2016 Dec 31. No abstract available.

PMID:
28043802
32.

Pharmacist-led medication review in community settings: An overview of systematic reviews.

Jokanovic N, Tan EC, Sudhakaran S, Kirkpatrick CM, Dooley MJ, Ryan-Atwood TE, Bell JS.

Res Social Adm Pharm. 2017 Jul - Aug;13(4):661-685. doi: 10.1016/j.sapharm.2016.08.005. Epub 2016 Aug 28. Review.

PMID:
27665364
33.
34.

New Landmark for Localizing the Site of the Subdental Synchondrosis Remnant: Application to Discerning Pathology from Normal on Imaging.

Tubbs RS, Kirkpatrick CM, Fisahn C, Iwanaga J, Moisi MD, Hanscom DR, Chapman JR, Oskouian RJ.

World Neurosurg. 2016 Dec;96:80-84. doi: 10.1016/j.wneu.2016.08.096. Epub 2016 Aug 31.

PMID:
27591099
35.

Lithium in Paediatric Patients with Bipolar Disorder: Implications for Selection of Dosage Regimens via Population Pharmacokinetics/Pharmacodynamics.

Landersdorfer CB, Findling RL, Frazier JA, Kafantaris V, Kirkpatrick CM.

Clin Pharmacokinet. 2017 Jan;56(1):77-90. doi: 10.1007/s40262-016-0430-3.

PMID:
27393139
36.

Prioritizing interventions to manage polypharmacy in Australian aged care facilities.

Jokanovic N, Wang KN, Dooley MJ, Lalic S, Tan EC, Kirkpatrick CM, Bell JS.

Res Social Adm Pharm. 2017 May - Jun;13(3):564-574. doi: 10.1016/j.sapharm.2016.06.003. Epub 2016 Jun 15.

PMID:
27374998
37.

Disruptive innovation in community pharmacy - Impact of automation on the pharmacist workforce.

Spinks J, Jackson J, Kirkpatrick CM, Wheeler AJ.

Res Social Adm Pharm. 2017 Mar - Apr;13(2):394-397. doi: 10.1016/j.sapharm.2016.04.009. Epub 2016 May 14.

PMID:
27283243
38.

Effect of different renal function on antibacterial effects of piperacillin against Pseudomonas aeruginosa evaluated via the hollow-fibre infection model and mechanism-based modelling.

Bergen PJ, Bulitta JB, Kirkpatrick CM, Rogers KE, McGregor MJ, Wallis SC, Paterson DL, Lipman J, Roberts JA, Landersdorfer CB.

J Antimicrob Chemother. 2016 Sep;71(9):2509-20. doi: 10.1093/jac/dkw153. Epub 2016 May 26.

PMID:
27231278
39.

Clinically relevant concentrations of fosfomycin combined with polymyxin B, tobramycin or ciprofloxacin enhance bacterial killing of Pseudomonas aeruginosa, but do not suppress the emergence of fosfomycin resistance.

Walsh CC, Landersdorfer CB, McIntosh MP, Peleg AY, Hirsch EB, Kirkpatrick CM, Bergen PJ.

J Antimicrob Chemother. 2016 Aug;71(8):2218-29. doi: 10.1093/jac/dkw115. Epub 2016 Apr 26.

PMID:
27118778
40.

Spontaneously reported haemorrhagic adverse events associated with rivaroxaban and dabigatran in Australia.

Chen EY, Diug B, Bell JS, Mc Namara KP, Dooley MJ, Kirkpatrick CM, McNeil JJ, Caughey GE, Ilomäki J.

Ther Adv Drug Saf. 2016 Feb;7(1):4-10. doi: 10.1177/2042098615618171.

41.

Why is polypharmacy increasing in aged care facilities? The views of Australian health care professionals.

Jokanovic N, Tan EC, Dooley MJ, Kirkpatrick CM, Elliott RA, Bell JS.

J Eval Clin Pract. 2016 Oct;22(5):677-82. doi: 10.1111/jep.12514. Epub 2016 Jan 25.

PMID:
26804719
42.

Effects of Changes in Number of Medications and Drug Burden Index Exposure on Transitions Between Frailty States and Death: The Concord Health and Ageing in Men Project Cohort Study.

Jamsen KM, Bell JS, Hilmer SN, Kirkpatrick CM, Ilomäki J, Le Couteur D, Blyth FM, Handelsman DJ, Waite L, Naganathan V, Cumming RG, Gnjidic D.

J Am Geriatr Soc. 2016 Jan;64(1):89-95. doi: 10.1111/jgs.13877.

PMID:
26782856
43.

Do the cerebellar tonsils move during flexion and extension of the neck in patients with Chiari I malformation? A radiological study with clinical implications.

Tubbs RS, Kirkpatrick CM, Rizk E, Chern JJ, Oskouian RJ, Oakes WJ.

Childs Nerv Syst. 2016 Mar;32(3):527-30. doi: 10.1007/s00381-016-3014-5. Epub 2016 Jan 12.

PMID:
26758883
44.

Safe disposal of prescribed medicines.

Bergen PJ, Hussainy SY, George J, Kong DC, Kirkpatrick CM.

Aust Prescr. 2015 Jun;38(3):90-2. Epub 2015 Jun 1. Review.

45.

Primary antifungal prophylaxis in adult patients with acute lymphoblastic leukaemia: a multicentre audit.

Doan TN, Kirkpatrick CM, Walker P, Slavin MA, Ananda-Rajah MR, Morrissey CO, Urbancic KF, Grigg A, Spencer A, Szer J, Seymour JF, Kong DC.

J Antimicrob Chemother. 2016 Feb;71(2):497-505. doi: 10.1093/jac/dkv343. Epub 2015 Oct 30.

PMID:
26518050
46.

Modeling the impact of interventions against Acinetobacter baumannii transmission in intensive care units.

Doan TN, Kong DC, Marshall C, Kirkpatrick CM, McBryde ES.

Virulence. 2016;7(2):141-52. doi: 10.1080/21505594.2015.1076615. Epub 2015 Aug 7.

47.

Clinical medication review in Australia: A systematic review.

Jokanovic N, Tan EC, van den Bosch D, Kirkpatrick CM, Dooley MJ, Bell JS.

Res Social Adm Pharm. 2016 May-Jun;12(3):384-418. doi: 10.1016/j.sapharm.2015.06.007. Epub 2015 Jul 9. Review.

PMID:
26250049
48.

In vitro pharmacodynamics of fosfomycin against clinical isolates of Pseudomonas aeruginosa.

Walsh CC, McIntosh MP, Peleg AY, Kirkpatrick CM, Bergen PJ.

J Antimicrob Chemother. 2015 Nov;70(11):3042-50. doi: 10.1093/jac/dkv221. Epub 2015 Jul 24.

PMID:
26209311
49.

Characterising the Transmission Dynamics of Acinetobacter baumannii in Intensive Care Units Using Hidden Markov Models.

Doan TN, Kong DC, Marshall C, Kirkpatrick CM, McBryde ES.

PLoS One. 2015 Jul 1;10(7):e0132037. doi: 10.1371/journal.pone.0132037. eCollection 2015.

50.

The Reporting Of MEdication use in Observational studies (ROMEO) Statement.

Poole SG, Bell JS, Dooley MJ, Kirkpatrick CM; ROMEO Consensus Group.

Eur J Clin Pharmacol. 2015 Jul;71(7):897-9. doi: 10.1007/s00228-015-1851-x. Epub 2015 May 9. No abstract available.

PMID:
25956714

Supplemental Content

Loading ...
Support Center